LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Farah, Mohamed H"
  2. AU="Sismondo, Sergio"

Search results

Result 1 - 10 of total 41

Search options

  1. Article: Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders.

    Marshall, Katherine L / Farah, Mohamed H

    Neural regeneration research

    2021  Volume 16, Issue 10, Page(s) 1901–1910

    Abstract: Nervous system disorders are prevalent health issues that will only continue to increase in frequency as the population ages. Dying-back axonopathy is a hallmark of many neurologic diseases and leads to axonal disconnection from their targets, which in ... ...

    Abstract Nervous system disorders are prevalent health issues that will only continue to increase in frequency as the population ages. Dying-back axonopathy is a hallmark of many neurologic diseases and leads to axonal disconnection from their targets, which in turn leads to functional impairment. During the course of many of neurologic diseases, axons can regenerate or sprout in an attempt to reconnect with the target and restore synapse function. In amyotrophic lateral sclerosis (ALS), distal motor axons retract from neuromuscular junctions early in the disease-course before significant motor neuron death. There is evidence of compensatory motor axon sprouting and reinnervation of neuromuscular junctions in ALS that is usually quickly overtaken by the disease course. Potential drugs that enhance compensatory sprouting and encourage reinnervation may slow symptom progression and retain muscle function for a longer period of time in ALS and in other diseases that exhibit dying-back axonopathy. There remain many outstanding questions as to the impact of distinct disease-causing mutations on axonal outgrowth and regeneration, especially in regards to motor neurons derived from patient induced pluripotent stem cells. Compartmentalized microfluidic chambers are powerful tools for studying the distal axons of human induced pluripotent stem cells-derived motor neurons, and have recently been used to demonstrate striking regeneration defects in human motor neurons harboring ALS disease-causing mutations. Modeling the human neuromuscular circuit with human induced pluripotent stem cells-derived motor neurons will be critical for developing drugs that enhance axonal regeneration, sprouting, and reinnervation of neuromuscular junctions. In this review we will discuss compensatory axonal sprouting as a potential therapeutic target for ALS, and the use of compartmentalized microfluidic devices to find drugs that enhance regeneration and axonal sprouting of motor axons.
    Language English
    Publishing date 2021-02-13
    Publishing country India
    Document type Journal Article ; Review
    ZDB-ID 2388460-5
    ISSN 1876-7958 ; 1673-5374
    ISSN (online) 1876-7958
    ISSN 1673-5374
    DOI 10.4103/1673-5374.308077
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The influence of BACE1 on macrophage recruitment and activity in the injured peripheral nerve.

    Fissel, John A / Farah, Mohamed H

    Journal of neuroinflammation

    2021  Volume 18, Issue 1, Page(s) 71

    Abstract: Following peripheral nerve injury, multiple cell types, including axons, Schwann cells, and macrophages, coordinate to promote nerve regeneration. However, this capacity for repair is limited, particularly in older populations, and current treatments are ...

    Abstract Following peripheral nerve injury, multiple cell types, including axons, Schwann cells, and macrophages, coordinate to promote nerve regeneration. However, this capacity for repair is limited, particularly in older populations, and current treatments are insufficient. A critical component of the regeneration response is the network of cell-to-cell signaling in the injured nerve microenvironment. Sheddases are expressed in the peripheral nerve and play a role in the regulation if this cell-to-cell signaling through cleavage of transmembrane proteins, enabling the regulation of multiple pathways through cis- and trans-cellular regulatory mechanisms. Enhanced axonal regeneration has been observed in mice with deletion of the sheddase beta-secretase (BACE1), a transmembrane aspartyl protease that has been studied in the context of Alzheimer's disease. BACE1 knockout (KO) mice display enhanced macrophage recruitment and activity following nerve injury, although it is unclear whether this plays a role in driving the enhanced axonal regeneration. Further, it is unknown by what mechanism(s) BACE1 increases macrophage recruitment and activity. BACE1 has many substrates, several of which are known to have immunomodulatory activity. This review will discuss current knowledge of the role of BACE1 and other sheddases in peripheral nerve regeneration and outline known immunomodulatory BACE1 substrates and what potential roles they could play in peripheral nerve regeneration. Currently, the literature suggests that BACE1 and substrates that are expressed by neurons and Schwann cells are likely to be more important for this process than those expressed by macrophages. More broadly, BACE1 may play a role as an effector of immunomodulation beyond the peripheral nerve.
    MeSH term(s) Amyloid Precursor Protein Secretases/genetics ; Animals ; Aspartic Acid Endopeptidases/genetics ; Humans ; Macrophages/pathology ; Nerve Regeneration/genetics ; Peripheral Nerve Injuries/genetics ; Peripheral Nerve Injuries/pathology ; Peripheral Nerves/pathology
    Chemical Substances Amyloid Precursor Protein Secretases (EC 3.4.-) ; Aspartic Acid Endopeptidases (EC 3.4.23.-) ; BACE1 protein, human (EC 3.4.23.46)
    Language English
    Publishing date 2021-03-15
    Publishing country England
    Document type Journal Article ; Review
    ISSN 1742-2094
    ISSN (online) 1742-2094
    DOI 10.1186/s12974-021-02121-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Macrophage-specific deletion of BACE1 does not enhance macrophage recruitment to the injured peripheral nerve.

    Fissel, John A / Farah, Mohamed H

    Journal of neuroimmunology

    2020  Volume 349, Page(s) 577423

    Abstract: Following peripheral nerve injury, macrophages are recruited to the injury site from circulation to clear cellular debris. Injured β-secretase 1 (BACE1) knockout mice have enhanced macrophage recruitment and debris clearance, which may be due to BACE1 ... ...

    Abstract Following peripheral nerve injury, macrophages are recruited to the injury site from circulation to clear cellular debris. Injured β-secretase 1 (BACE1) knockout mice have enhanced macrophage recruitment and debris clearance, which may be due to BACE1 activity in macrophages or the hypomyelination observed in BACE1 knockout mice. To assess if BACE1 expression by macrophages mediates enhanced macrophage recruitment we utilized mice with macrophage specific deletion of BACE1 and saw no increase in macrophage recruitment following injury. This study suggests that expression of BACE1 by macrophages may not be essential for increased recruitment observed previously in global BACE1 KO mice.
    MeSH term(s) Amyloid Precursor Protein Secretases/deficiency ; Animals ; Aspartic Acid Endopeptidases/deficiency ; Cells, Cultured ; Female ; Macrophages/metabolism ; Macrophages/pathology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Nerve Regeneration/physiology ; Peripheral Nerve Injuries/metabolism ; Peripheral Nerve Injuries/pathology
    Chemical Substances Amyloid Precursor Protein Secretases (EC 3.4.-) ; Aspartic Acid Endopeptidases (EC 3.4.23.-) ; Bace1 protein, mouse (EC 3.4.23.46)
    Language English
    Publishing date 2020-10-06
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 8335-5
    ISSN 1872-8421 ; 0165-5728
    ISSN (online) 1872-8421
    ISSN 0165-5728
    DOI 10.1016/j.jneuroim.2020.577423
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Enhanced axonal regeneration of ALS patient iPSC-derived motor neurons harboring SOD1

    Marshall, Katherine L / Rajbhandari, Labchan / Venkatesan, Arun / Maragakis, Nicholas J / Farah, Mohamed H

    Scientific reports

    2023  Volume 13, Issue 1, Page(s) 5597

    Abstract: Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, characterized by degeneration of upper and lower motor neurons that leads to muscle weakness, paralysis, and death, but the effects of disease-causing mutations on axonal ... ...

    Abstract Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, characterized by degeneration of upper and lower motor neurons that leads to muscle weakness, paralysis, and death, but the effects of disease-causing mutations on axonal outgrowth of neurons derived from human induced pluripotent stem cells (iPSC)-derived motor neurons (hiPSC-MN) are poorly understood. The use of hiPSC-MN is a promising tool to develop more relevant models for target identification and drug development in ALS research, but questions remain concerning the effects of distinct disease-causing mutations on axon regeneration. Mutations in superoxide dismutase 1 (SOD1) were the first to be discovered in ALS patients. Here, we investigated the effect of the SOD1
    MeSH term(s) Humans ; Amyotrophic Lateral Sclerosis/genetics ; Superoxide Dismutase-1/genetics ; Induced Pluripotent Stem Cells ; Axons ; Neurodegenerative Diseases ; Superoxide Dismutase/genetics ; Nerve Regeneration ; Motor Neurons/physiology ; Mutation
    Chemical Substances Superoxide Dismutase-1 (EC 1.15.1.1) ; Superoxide Dismutase (EC 1.15.1.1) ; SOD1 protein, human
    Language English
    Publishing date 2023-04-05
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-023-31720-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Beta secretase activity in peripheral nerve regeneration.

    Tallon, Carolyn / Farah, Mohamed H

    Neural regeneration research

    2017  Volume 12, Issue 10, Page(s) 1565–1574

    Abstract: While the peripheral nervous system has the capacity to regenerate following a nerve injury, it is often at a slow rate and results in unsatisfactory recovery, leaving patients with reduced function. Many regeneration associated genes have been ... ...

    Abstract While the peripheral nervous system has the capacity to regenerate following a nerve injury, it is often at a slow rate and results in unsatisfactory recovery, leaving patients with reduced function. Many regeneration associated genes have been identified over the years, which may shed some insight into how we can manipulate this intrinsic regenerative ability to enhance repair following peripheral nerve injuries. Our lab has identified the membrane bound protease beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1), or beta secretase, as a potential negative regulator of peripheral nerve regeneration. When beta secretase activity levels are abolished via a null mutation in mice, peripheral regeneration is enhanced following a sciatic nerve crush injury. Conversely, when activity levels are greatly increased by overexpressing beta secretase in mice, nerve regeneration and functional recovery are impaired after a sciatic nerve crush injury. In addition to our work, many substrates of beta secretase have been found to be involved in regulating neurite outgrowth and some have even been identified as regeneration associated genes. In this review, we set out to discuss BACE1 and its substrates with respect to axonal regeneration and speculate on the possibility of utilizing BACE1 inhibitors to enhance regeneration following acute nerve injury and potential uses in peripheral neuropathies.
    Language English
    Publishing date 2017-11-09
    Publishing country India
    Document type Journal Article ; Review
    ZDB-ID 2388460-5
    ISSN 1876-7958 ; 1673-5374
    ISSN (online) 1876-7958
    ISSN 1673-5374
    DOI 10.4103/1673-5374.217319
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: BACE1 influences debris clearance and axonal regeneration in injured peripheral nerve.

    Farah, Mohamed H

    Journal of the peripheral nervous system : JPNS

    2012  Volume 17 Suppl 3, Page(s) 30–33

    Abstract: During 3 years, my research activities in Jack Griffin's laboratory focused on the influence of β-amyloid precursor protein cleaving enzyme 1 (BACE1) on the degeneration/regeneration of sciatic nerve of mice. Here, potential mechanisms of how BACE1 ... ...

    Abstract During 3 years, my research activities in Jack Griffin's laboratory focused on the influence of β-amyloid precursor protein cleaving enzyme 1 (BACE1) on the degeneration/regeneration of sciatic nerve of mice. Here, potential mechanisms of how BACE1 enzymatic activity influences these processes are discussed.
    MeSH term(s) Amyloid Precursor Protein Secretases/metabolism ; Animals ; Aspartic Acid Endopeptidases/metabolism ; Mice ; Nerve Regeneration/physiology ; Peripheral Nerves/metabolism ; Phagocytosis/physiology
    Chemical Substances Amyloid Precursor Protein Secretases (EC 3.4.-) ; Aspartic Acid Endopeptidases (EC 3.4.23.-) ; Bace1 protein, mouse (EC 3.4.23.46)
    Language English
    Publishing date 2012-12
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1364009-4
    ISSN 1529-8027 ; 1085-9489
    ISSN (online) 1529-8027
    ISSN 1085-9489
    DOI 10.1111/j.1529-8027.2012.00428.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy.

    Farah, Mohamed H / Dali, Christine Í / Groeschel, Samuel / Moldovan, Mihai / Whiteman, David A H / Malanga, C J / Krägeloh-Mann, Ingeborg / Li, Jing / Barton, Norman / Krarup, Christian

    Annals of clinical and translational neurology

    2023  Volume 11, Issue 2, Page(s) 328–341

    Abstract: Objective: To evaluate the longitudinal correlations between sulfatide/lysosulfatide levels and central and peripheral nervous system function in children with metachromatic leukodystrophy (MLD) and to explore the impact of intravenous recombinant human ...

    Abstract Objective: To evaluate the longitudinal correlations between sulfatide/lysosulfatide levels and central and peripheral nervous system function in children with metachromatic leukodystrophy (MLD) and to explore the impact of intravenous recombinant human arylsulfatase A (rhASA) treatment on myelin turnover.
    Methods: A Phase 1/2 study of intravenous rhASA investigated cerebrospinal fluid (CSF) and sural nerve sulfatide levels, 88-item Gross Motor Function Measure (GMFM-88) total score, sensory and motor nerve conduction, brain N-acetylaspartate (NAA) levels, and sural nerve histology in 13 children with MLD. Myelinated and unmyelinated nerves from an untreated MLD mouse model were also analyzed.
    Results: CSF sulfatide levels correlated with neither Z-scores for GMFM-88 nor brain NAA levels; however, CSF sulfatide levels correlated negatively with Z-scores of nerve conduction parameters, number of large (≥7 μm) myelinated fibers, and myelin/fiber diameter slope, and positively with nerve g-ratios and cortical latencies of somatosensory-evoked potentials. Quantity of endoneural litter positively correlated with sural nerve sulfatide/lysosulfatide levels. CSF sulfatide levels decreased with continuous high-dose treatment; this change correlated with improved nerve conduction. At 26 weeks after treatment, nerve g-ratio decreased by 2%, and inclusion bodies per Schwann cell unit increased by 55%. In mice, abnormal sulfatide storage was observed in non-myelinating Schwann cells in Remak bundles of sciatic nerves but not in unmyelinated urethral nerves.
    Interpretation: Lower sulfatide levels in the CSF and peripheral nerves correlate with better peripheral nerve function in children with MLD; intravenous rhASA treatment may reduce CSF sulfatide levels and enhance sulfatide/lysosulfatide processing and remyelination in peripheral nerves.
    MeSH term(s) Child ; Humans ; Mice ; Animals ; Leukodystrophy, Metachromatic/drug therapy ; Sulfoglycosphingolipids/pharmacology ; Cerebroside-Sulfatase ; Sciatic Nerve/pathology ; Psychosine/analogs & derivatives
    Chemical Substances Sulfoglycosphingolipids ; Cerebroside-Sulfatase (EC 3.1.6.8) ; psychosine-3'-sulfate ester (70005-46-8) ; Psychosine (2238-90-6)
    Language English
    Publishing date 2023-12-26
    Publishing country United States
    Document type Clinical Trial, Phase II ; Clinical Trial, Phase I ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2740696-9
    ISSN 2328-9503 ; 2328-9503
    ISSN (online) 2328-9503
    ISSN 2328-9503
    DOI 10.1002/acn3.51954
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Pharmacological BACE Inhibition Improves Axonal Regeneration in Nerve Injury and Disease Models.

    Tallon, Carolyn / Marshall, Katherine L / Kennedy, Matthew E / Hyde, Lynn A / Farah, Mohamed H

    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

    2020  Volume 17, Issue 3, Page(s) 973–988

    Abstract: While the peripheral nervous system is able to repair itself following injury and disease, recovery is often slow and incomplete, with no available treatments to enhance the effectiveness of regeneration. Using knock-out and transgenic overexpressor mice, ...

    Abstract While the peripheral nervous system is able to repair itself following injury and disease, recovery is often slow and incomplete, with no available treatments to enhance the effectiveness of regeneration. Using knock-out and transgenic overexpressor mice, we previously reported that BACE1, an aspartyl protease, as reported by Hemming et al. (PLoS One 4:12, 2009), negatively regulates peripheral nerve regeneration. Here, we investigated whether pharmacological inhibition of BACE may enhance peripheral nerve repair following traumatic nerve injury or neurodegenerative disease. BACE inhibitor-treated mice had increased numbers of regenerating axons and enhanced functional recovery after a sciatic nerve crush while inhibition increased axonal sprouting following a partial nerve injury. In the SOD1
    MeSH term(s) Amyloid Precursor Protein Secretases/antagonists & inhibitors ; Amyloid Precursor Protein Secretases/metabolism ; Amyotrophic Lateral Sclerosis/drug therapy ; Amyotrophic Lateral Sclerosis/enzymology ; Amyotrophic Lateral Sclerosis/genetics ; Animals ; Aspartic Acid Endopeptidases/antagonists & inhibitors ; Aspartic Acid Endopeptidases/metabolism ; Axons/drug effects ; Axons/physiology ; Cells, Cultured ; Disease Models, Animal ; Enzyme Inhibitors/pharmacology ; Enzyme Inhibitors/therapeutic use ; Female ; HEK293 Cells ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mice, Transgenic ; Nerve Regeneration/drug effects ; Nerve Regeneration/physiology ; Peripheral Nerve Injuries/drug therapy ; Peripheral Nerve Injuries/enzymology ; Peripheral Nerve Injuries/genetics ; Superoxide Dismutase/genetics
    Chemical Substances Enzyme Inhibitors ; SOD1 G93A protein (EC 1.15.1.1) ; Superoxide Dismutase (EC 1.15.1.1) ; Amyloid Precursor Protein Secretases (EC 3.4.-) ; Aspartic Acid Endopeptidases (EC 3.4.23.-) ; Bace1 protein, mouse (EC 3.4.23.46)
    Language English
    Publishing date 2020-03-02
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2316693-9
    ISSN 1878-7479 ; 1933-7213
    ISSN (online) 1878-7479
    ISSN 1933-7213
    DOI 10.1007/s13311-020-00852-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: RNAi silencing in mouse models of neurodegenerative diseases.

    Farah, Mohamed H

    Current drug delivery

    2007  Volume 4, Issue 2, Page(s) 161–167

    Abstract: RNA interference (RNAi) has emerged as a potential therapeutic approach for neurodegenerative diseases, particularly those associated with autosomal dominant patterns of inheritance. In proof of concept experiments, several groups have demonstrated ... ...

    Abstract RNA interference (RNAi) has emerged as a potential therapeutic approach for neurodegenerative diseases, particularly those associated with autosomal dominant patterns of inheritance. In proof of concept experiments, several groups have demonstrated efficacy of using viral vectors expressing short hairpin RNA (shRNA) directed against therapeutically relevant genes in mouse models of neurodegenerative diseases, including spinocerebellar ataxia, Amyotrophic Lateral Sclerosis, Huntington's Disease and amyloidosis (a pathological aspect of Alzheimer's Disease). Although viral-based RNAi has limitations that most likely will preclude its usage in humans, a few recent developments underscore the potential of non-viral-based delivery of relevant RNAi as therapeutics for neurodegenerative diseases. Here, I will review the recent literature on effectiveness of RNAi as a therapeutic strategy in mouse models of neurodegenerative diseases.
    MeSH term(s) Alzheimer Disease/genetics ; Alzheimer Disease/metabolism ; Alzheimer Disease/therapy ; Amyloid Precursor Protein Secretases/genetics ; Amyloid Precursor Protein Secretases/metabolism ; Amyloidosis/genetics ; Amyloidosis/metabolism ; Amyloidosis/therapy ; Amyotrophic Lateral Sclerosis/genetics ; Amyotrophic Lateral Sclerosis/metabolism ; Amyotrophic Lateral Sclerosis/therapy ; Animals ; Aspartic Acid Endopeptidases/genetics ; Aspartic Acid Endopeptidases/metabolism ; Ataxin-1 ; Ataxins ; Blood-Brain Barrier ; Disease Models, Animal ; Gene Transfer Techniques ; Genetic Therapy/methods ; Genetic Vectors ; Huntingtin Protein ; Huntington Disease/genetics ; Huntington Disease/metabolism ; Huntington Disease/therapy ; Mice ; Nerve Tissue Proteins/genetics ; Nerve Tissue Proteins/metabolism ; Neurodegenerative Diseases/genetics ; Neurodegenerative Diseases/metabolism ; Neurodegenerative Diseases/therapy ; Nuclear Proteins/genetics ; Nuclear Proteins/metabolism ; RNA Interference ; RNA, Double-Stranded/genetics ; RNA, Double-Stranded/metabolism ; RNA, Small Interfering/biosynthesis ; RNA, Small Interfering/genetics ; Spinocerebellar Ataxias/genetics ; Spinocerebellar Ataxias/metabolism ; Spinocerebellar Ataxias/therapy ; Superoxide Dismutase/genetics ; Superoxide Dismutase/metabolism ; Superoxide Dismutase-1
    Chemical Substances ATXN1 protein, human ; Ataxin-1 ; Ataxins ; Atxn1 protein, mouse ; Htt protein, mouse ; Huntingtin Protein ; Nerve Tissue Proteins ; Nuclear Proteins ; RNA, Double-Stranded ; RNA, Small Interfering ; SOD1 protein, human ; Sod1 protein, mouse (EC 1.15.1.1) ; Superoxide Dismutase (EC 1.15.1.1) ; Superoxide Dismutase-1 (EC 1.15.1.1) ; Amyloid Precursor Protein Secretases (EC 3.4.-) ; Aspartic Acid Endopeptidases (EC 3.4.23.-) ; Bace1 protein, mouse (EC 3.4.23.46)
    Language English
    Publishing date 2007-04-12
    Publishing country United Arab Emirates
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2185284-4
    ISSN 1875-5704 ; 1567-2018
    ISSN (online) 1875-5704
    ISSN 1567-2018
    DOI 10.2174/156720107780362276
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Neurogenesis and cell death in the ganglion cell layer of vertebrate retina.

    Farah, Mohamed H

    Brain research reviews

    2006  Volume 52, Issue 2, Page(s) 264–274

    Abstract: The correct formation of all central nervous system tissues depends on the proper balance of neurogenesis and developmental cell death. A model system for studying these programs is the ganglion cell layer (GCL) of the vertebrate retina because of its ... ...

    Abstract The correct formation of all central nervous system tissues depends on the proper balance of neurogenesis and developmental cell death. A model system for studying these programs is the ganglion cell layer (GCL) of the vertebrate retina because of its simple and well-described structure and amenability to experimental manipulations. The GCL contains approximately equal numbers of ganglion cells and displaced amacrine cells. Ganglion cells are the first or among the first cells born in the retina in all the studied vertebrates. Neurogenesis and cell death have been studied extensively in the GCL of various amniotes (rodents, chicks, and monkeys) and anamniotes (fish and frogs), and the two processes highlight developmental differences between the groups. In amniotes, neurogenesis occurs during a defined period prior to birth/hatch or the opening of the eyes, whereas in anamniotes, neurogenesis extends past hatching into adulthood-sometimes for years. Roughly half of GCL neurons die during development in amniotes, whereas developmental cell death does not occur in the GCL neurons of anamniotes. This review discusses the spatial and temporal patterns of neurogenesis, cell death, and possible explanation of cell death in the GCL. It also examines markers widely used to distinguish between ganglion cells and displaced amacrine cells, and methods employed to birth date neurons.
    MeSH term(s) Amacrine Cells/cytology ; Amacrine Cells/physiology ; Animals ; Cell Death/physiology ; Cell Differentiation/physiology ; Cell Lineage/physiology ; Growth Cones/physiology ; Growth Cones/ultrastructure ; Humans ; Nerve Growth Factors/metabolism ; Retina/cytology ; Retina/embryology ; Retina/growth & development ; Retinal Ganglion Cells/cytology ; Retinal Ganglion Cells/physiology ; Species Specificity ; Stem Cells/cytology ; Stem Cells/physiology ; Vertebrates/embryology ; Vertebrates/growth & development
    Chemical Substances Nerve Growth Factors
    Language English
    Publishing date 2006-09
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 423722-5
    ISSN 1872-6321 ; 0165-0173
    ISSN (online) 1872-6321
    ISSN 0165-0173
    DOI 10.1016/j.brainresrev.2006.04.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top